Search - tctmd.com

Displaying 221 - 240 of 267

Sort: Relevancy | Date

Presentation TCT 2015

Low-Flow, Low-Gradient Aortic Stenosis: How to Diagnosis, and Should We Treat?

Presenter: Jeroen J. Bax, Paul A. Grayburn, Philippe Pibarot

October 15, 2015

Presentation TCT 2015

LAA Closure vs Pharmacotherapy (Including NOACs) in a Patient With AF and Intermediate Risk of Bleeding Focused Commentary

Presenter: Martin B. Leon, Mark Reisman, Chet Rihal, Martin W Bergmann

October 15, 2015

Presentation TCT 2015

LAA Closure vs Pharmacotherapy (Including NOACs) in a Patient With AF and Intermediate Risk of Bleeding

Presenter: Martin B. Leon, Mark Reisman, Chet Rihal, Brij Maini

October 15, 2015

Presentation TCT 2015

Severe Functional MR + Symptoms With Slightly Reduced LVEF (45%) and Moderate Surgical Risk: Treatment Options Focused Commentary

Presenter: Martin B. Leon, Mark Reisman, Chet Rihal, Alec S. Vahanian

October 15, 2015

Presentation TCT 2015

Severe Functional MR + Symptoms With Slightly Reduced LVEF (45%) and Moderate Surgical Risk: Treatment Options

Presenter: Martin B. Leon, Mark Reisman, Chet Rihal, Olaf Franzen

October 15, 2015

Presentation TCT 2015

Severe AS + Symptoms in an 80-Year-Old With Low Surgical Risk: TAVR or Surgery?

Presenter: Martin B. Leon, Mark Reisman, Chet Rihal, Axel Linke

October 15, 2015

Presentation TCT 2015

Transcatheter Annuloplasty and Mitral Valve Replacement: Emerging Therapeutic Options

Presenter: Blase A. Carabello, Howard C. Herrmann

October 12, 2015

Presentation TCT 2015

Transcatheter Mitral Therapies in 2015: MitraClip in Trials and the Real World

Presenter: Blase A. Carabello, Howard C. Herrmann, Ted E. Feldman

October 12, 2015

Presentation TCT 2015

What Will TAVR Look Like in 2 and 10 Years From Now?

Presenter: Blase A. Carabello, Howard C. Herrmann, Duane S. Pinto

October 12, 2015

Presentation TCT 2015

TAVR 2015: Current Status

Presenter: Blase A. Carabello, Howard C. Herrmann, James B. Hermiller Jr

October 12, 2015

Presentation TCT 2015

Guideline Update: Whats New, and Whats Left Unsaid?

Presenter: Blase A. Carabello, Howard C. Herrmann

October 12, 2015

Presentation TCT 2015

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Presenter: Zoltan G. Turi, Rahul Sakhuja

October 12, 2015

Presentation TCT 2015

Valvular Heart Disease: Treatment of Mitral Stenosis and Mitral Regurgitation

Presenter: Michael J. Lim, Molly Szerlip

October 12, 2015

Presentation TVT 2015

ESC/EACTS 2012 and ACC/AHA 2014 Valvular Heart Disease Guidelines: Where Do They Disagree?

Presenter: Gregg W. Stone, Alec S. Vahanian, John D. Carroll

June 05, 2015

Presentation TVT 2015

ESC/EACTS 2012 and ACC/AHA 2014 Valvular Heart Disease Guidelines: Where Do They Agree?

Presenter: Gregg W. Stone, Alec S. Vahanian, Allan Schwartz

June 05, 2015

Presentation ECHO 2015

Tips and Tricks for Imaging Valvular Heart Disease

Presenter: Omar Khalique

April 28, 2015

Presentation ECHO 2015

The Role of 3-D Echo in Valvular Heart Disease

Presenter: Omar K. Khalique

April 27, 2015

Presentation ECHO 2015

Right Heart Valvular Disease: When to Intervene

Presenter: Rebecca T. Hahn

April 27, 2015

Presentation ECHO 2015

Case Studies to Illustrate Pitfalls in Quantification of Valvular Heart Disease

Presenter: Mario J Garcia

April 27, 2015

Presentation ECHO 2015

3-D Echocardiography for Valvular Heart Disease

Presenter: Rebecca T. Hahn

April 27, 2015

Advertisement

Low-Flow, Low-Gradient Aortic Stenosis: How to Diagnosis, and Should We Treat?

LAA Closure vs Pharmacotherapy (Including NOACs) in a Patient With AF and Intermediate Risk of Bleeding Focused Commentary

LAA Closure vs Pharmacotherapy (Including NOACs) in a Patient With AF and Intermediate Risk of Bleeding

Severe Functional MR + Symptoms With Slightly Reduced LVEF (45%) and Moderate Surgical Risk: Treatment Options Focused Commentary

Severe Functional MR + Symptoms With Slightly Reduced LVEF (45%) and Moderate Surgical Risk: Treatment Options

Severe AS + Symptoms in an 80-Year-Old With Low Surgical Risk: TAVR or Surgery?

Transcatheter Annuloplasty and Mitral Valve Replacement: Emerging Therapeutic Options

Transcatheter Mitral Therapies in 2015: MitraClip in Trials and the Real World

What Will TAVR Look Like in 2 and 10 Years From Now?

TAVR 2015: Current Status

Guideline Update: Whats New, and Whats Left Unsaid?

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Valvular Heart Disease: Treatment of Mitral Stenosis and Mitral Regurgitation

ESC/EACTS 2012 and ACC/AHA 2014 Valvular Heart Disease Guidelines: Where Do They Disagree?

ESC/EACTS 2012 and ACC/AHA 2014 Valvular Heart Disease Guidelines: Where Do They Agree?

Tips and Tricks for Imaging Valvular Heart Disease

The Role of 3-D Echo in Valvular Heart Disease

Right Heart Valvular Disease: When to Intervene

Case Studies to Illustrate Pitfalls in Quantification of Valvular Heart Disease

3-D Echocardiography for Valvular Heart Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content